BetterLife Secures Mitacs Funding in Collaboration with Carleton University Research Team for TD-0148A Preclinical Depression Studies
As part of the Accelerate Program funded by Mitacs, Dr. Argel Aguilar-Valles team will work with BetterLife to test TD-0148A in both in vitro and in vivo models that are established in their lab.
- As part of the Accelerate Program funded by Mitacs, Dr. Argel Aguilar-Valles team will work with BetterLife to test TD-0148A in both in vitro and in vivo models that are established in their lab.
- Dr. Argel Aguilar-Valles said, We are delighted to have Mitacs support to examine BetterLifes TD-0148A in our established animal depression models.
- Carleton Neuroscience has an international reputation for research on stress and its effects on brain functioning and mental health.
- Mitacs is a not-for-profit organization that fosters growth and innovation in Canada by solving business challenges with research solutions from academic institutions.